Gene: PADI3
Official Full Name: peptidyl arginine deiminase 3provided by HGNC
Gene Summary: This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type III enzyme modulates hair structural proteins, such as filaggrin in the hair follicle and trichohyalin in the inner root sheath, during hair follicle formation. Together with the type I enzyme, this enzyme may also play a role in terminal differentiation of the epidermis. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22265 | PADI3 Knockout cell line (A549) | Human | PADI3 | 1:3~1:4 | Negative | Online Inquiry |
PADI3 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the effects of the PADI3 gene, which encodes for the enzyme peptidylarginine deiminase 3. This enzyme is involved in the post-translational modification of proteins through the process of citrullination, fundamentally altering protein function and influencing various physiological processes. By creating knockout cell lines, researchers enable the complete absence of PADI3 expression, allowing for comprehensive investigations into its role in cellular pathways, gene expression, and disease mechanisms.
The primary function of these knockout cell lines is to facilitate the analysis of the biological consequences of PADI3 deficiency. Utilizing CRISPR/Cas9 gene-editing technology, the knockout cell lines exhibit stable phenotypic changes that serve as a powerful tool for elucidating the molecular roles of PADI3 in conditions such as autoimmune diseases, cancers, and neurodegenerative disorders. Their use in functional assays, proteomic studies, and drug-screening applications enhances the understanding of disease pathology and paves the way for novel therapeutic approaches.
The scientific relevance of PADI3 Gene Knockout Cell Lines is underscored by their capacity to replicate certain human disease models, thus providing a more predictive platform for drug efficacy and safety assessments compared to traditional models. Compared to alternative models, these knockout cell lines offer greater specificity and biological relevance, making them indispensable for researchers focusing on citrullination processes and their implications in health and disease.
For researchers and clinicians, the adoption of PADI3 Gene Knockout Cell Lines represents a strategic advantage in advancing their research endeavors. These cell lines can help uncover intricate details about protein modifications and their impact on cellular behavior, yielding insights critical for developing targeted therapies.
Our company specializes in the development and production of innovative biological products designed to meet the evolving needs of the scientific community. With a strong commitment to quality and scientific integrity, we provide researchers with the tools necessary to advance their understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.